Innovator Ibd 50 Etf Profile

FFTY Etf  USD 25.78  0.15  0.58%   

Performance

3 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 9

 
High
 
Low
Low
Innovator IBD is trading at 25.78 as of the 25th of April 2024; that is -0.58% down since the beginning of the trading day. The etf's open price was 25.93. Innovator IBD has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Innovator IBD 50 are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of January 2024 and ending today, the 25th of April 2024. Click here to learn more.
The fund will normally invest at least 80 percent of its net assets in securities that comprise the index. Innovator Ibd is traded on NYSEARCA Exchange in the United States. More on Innovator IBD 50

Moving together with Innovator Etf

  0.87VOT Vanguard Mid CapPairCorr
  0.92IWP iShares Russell MidPairCorr
  0.75ARKK ARK Innovation ETF Aggressive PushPairCorr
  0.74IJK iShares SP MidPairCorr
  0.9KOMP SPDR Kensho NewPairCorr
  0.74MDYG SPDR SP 400PairCorr
  0.87IMCG iShares Morningstar MidPairCorr

Innovator Etf Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Innovator IBD's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Innovator IBD or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationMid-Cap Growth, Innovator ETFs (View all Sectors)
Country NameUSA
Returns Y T D6.29
NameInnovator IBD 50 ETF
Currency CodeUSD
In Threey Volatility27.01
1y Volatility24.93
200 Day M A24.482
50 Day M A26.9328
CodeFFTY
Updated At24th of April 2024
Currency NameUS Dollar
In Threey Sharp Ratio(0.5)
TypeETF
Innovator IBD 50 [FFTY] is traded in USA and was established 2015-04-08. The fund is listed under Mid-Cap Growth category and is part of Innovator ETFs family. Innovator IBD 50 currently have 97.73 M in assets under management (AUM). , while the total return for the last 3 years was -16.8%.
Check Innovator IBD Probability Of Bankruptcy

Sector Allocation

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Innovator Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Innovator Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Innovator IBD 50 Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.

Top Innovator IBD 50 Etf Constituents

CFCF Industries HoldingsStockMaterials
CELHCelsius HoldingsStockConsumer Staples
GLOBGlobant SAStockInformation Technology
FIVEFive BelowStockConsumer Discretionary
TALTAL Education GroupStockConsumer Discretionary
TTGTTechTargetStockCommunication Services
GNRCGenerac HoldingsStockIndustrials
More Details

Innovator IBD Target Price Odds Analysis

Based on a normal probability distribution, the odds of Innovator IBD jumping above the current price in 90 days from now is about 80.1%. The Innovator IBD 50 probability density function shows the probability of Innovator IBD etf to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the etf has a beta coefficient of 1.7104. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Innovator IBD will likely underperform. Additionally, innovator IBD 50 has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 25.78HorizonTargetOdds Above 25.78
19.68%90 days
 25.78 
80.10%
Based on a normal probability distribution, the odds of Innovator IBD to move above the current price in 90 days from now is about 80.1 (This Innovator IBD 50 probability density function shows the probability of Innovator Etf to fall within a particular range of prices over 90 days) .

Innovator IBD Top Holders

ADOAXAcm Dynamic OpportunityMutual FundLong-Short Equity
ADOIXAcm Dynamic OpportunityMutual FundLong-Short Equity
NAVFXThe Sector RotationMutual FundLarge Growth
More Details

Innovator IBD 50 Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Innovator IBD market risk premium is the additional return an investor will receive from holding Innovator IBD long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Innovator IBD. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Innovator IBD's alpha and beta are two of the key measurements used to evaluate Innovator IBD's performance over the market, the standard measures of volatility play an important role as well.

Innovator IBD Against Markets

Picking the right benchmark for Innovator IBD etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Innovator IBD etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Innovator IBD is critical whether you are bullish or bearish towards Innovator IBD 50 at a given time. Please also check how Innovator IBD's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Innovator IBD without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

How to buy Innovator Etf?

Before investing in Innovator IBD, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Innovator IBD. To buy Innovator IBD etf, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Innovator IBD. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Innovator IBD etf. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Innovator IBD 50 etf in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Innovator IBD 50 etf, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the etf
It's important to note that investing in stocks, such as Innovator IBD 50, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in etf prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Innovator Etf please use our How to Invest in Innovator IBD guide.

Already Invested in Innovator IBD 50?

The danger of trading Innovator IBD 50 is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Innovator IBD is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Innovator IBD. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Innovator IBD 50 is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Innovator IBD 50 offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innovator IBD's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innovator Ibd 50 Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Innovator Ibd 50 Etf:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Innovator IBD 50. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator IBD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.